|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heist RS and Engelman JA: SnapShot:
non-small cell lung cancer. Cancer Cell. 21:448.e22012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng L, Xie Y, Zhang H and Wu Y:
Down-regulation of NDRG2 gene expression in human colorectal cancer
involves promoter methylation and microRNA-650. Biochem Biophys Res
Commun. 406:534–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang YQ, Tian T, Zhu HY, Liang JH, Wu W,
Wu JZ, Xia Y, Wang L, Fan L, Li JY, et al: NDRG2 mRNA levels and
miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC
Cancer. 18:10092018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yun JH, Moon S, Lee HS, Hwang MY, Kim YJ,
Yu HY, Kim Y, Han BG, Kim BJ and Kim JM: MicroRNA-650 in a copy
number-variable region regulates the production of interleukin 6 in
human osteosarcoma cells. Oncol Lett. 10:2603–2609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun B, Pu B, Chu D, Chu X, Li W and Wei D:
MicroRNA-650 expression in glioma is associated with prognosis of
patients. J Neurooncol. 115:375–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mraz M, Dolezalova D, Plevova K, Stano
Kozubik K, Mayerova V, Cerna K, Musilova K, Tichy B, Pavlova S,
Borsky M, et al: MicroRNA-650 expression is influenced by
immunoglobulin gene rearrangement and affects the biology of
chronic lymphocytic leukemia. Blood. 119:2110–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin P, Chen H, Xie J, Zhou C and Zhu X:
Essential role of microRNA-650 in the regulation of B-cell
CLL/lymphoma 11B gene expression following transplantation: A novel
mechanism behind the acute rejection of renal allografts. Int J Mol
Med. 40:1840–1850. 2017.PubMed/NCBI
|
|
12
|
Ningning S, Libo S, Chuanbin W, Haijiang S
and Qing Z: MiR-650 regulates the proliferation, migration and
invasion of human oral cancer by targeting growth factor
independent 1 (Gfi1). Biochimie. 156:69–78. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan C, Xu L, Du P and Pang J: miRNA-650
exerts anti-leukemia activity by inhibiting cell proliferation
through Gfi1 targeting. Tumori. 104:369–374. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guérillon C, Bigot N and Pedeux R: The ING
tumor suppressor genes: Status in human tumors. Cancer Lett.
345:1–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Doyon Y, Cayrou C, Ullah M, Landry AJ,
Côté V, Selleck W, Lane WS, Tan S, Yang XJ and Côté J: ING tumor
suppressor proteins are critical regulators of chromatin
acetylation required for genome expression and perpetuation. Mol
Cell. 21:51–64. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagashima M, Shiseki M, Pedeux RM, Okamura
S, Kitahama-Shiseki M, Miura K, Yokota J and Harris CC: A novel
PHD-finger motif protein, p47ING3, modulates p53-mediated
transcription, cell cycle control, and apoptosis. Oncogene.
22:343–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui S, Gao Y, Zhang K, Chen J, Wang R and
Chen L: The emerging role of inhibitor of growth 4 as a tumor
suppressor in multiple human cancers. Cell Physiol Biochem.
36:409–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gunduz M, Nagatsuka H, Demircan K, Gunduz
E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K,
Beder L, et al: Frequent deletion and down-regulation of ING4, a
candidate tumor suppressor gene at 12p13, in head and neck squamous
cell carcinomas. Gene. 356:109–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Mou X, Wang S, Liu XE and Sun X:
ING4 expressing oncolytic vaccinia virus promotes anti-tumor
efficiency and synergizes with gemcitabine in pancreatic cancer.
Oncotarget. 8:82728–82739. 2017.PubMed/NCBI
|
|
20
|
Keenen MM and Kim S: Tumor suppressor ING4
inhibits estrogen receptor activity in breast cancer cells. Breast
Cancer (Dove Med Press). 8:211–221. 2016.PubMed/NCBI
|
|
21
|
Ren Y, Zhao S, Chen H, Fu YM and Zhao B:
Association between the expression of inhibitor of growth family
member 4 and the progression of clear cell renal carcinoma. Oncol
Lett. 14:2453–2457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Fu R, Xu M, Huang Y, Sun G and Xu
L: N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation
contributed to the angiogenesis of transformed human gastric
epithelial cells. Life Sci. 199:179–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai L, Li H, Chen C, Cheng X, Wang Y, Liu
J, Wang Y and Hao L: Role of inhibitor of growth 4 in the
suppression of human melanoma cells through the Fas/FasL-mediated
apoptosis pathway. Int J Mol Med. 41:1055–1061. 2018.PubMed/NCBI
|
|
24
|
Chen Y, Huang Y, Hou P, Zhang Z, Zhang Y,
Wang W, Sun G, Xu L, Zhou J, Bai J, et al: ING4 suppresses tumor
angiogenesis and functions as a prognostic marker in human
colorectal cancer. Oncotarget. 7:79017–79031. 2016.PubMed/NCBI
|
|
25
|
Pan X, Wang R, Bian H, De W, Zhang P, Wei
C and Wang Z: Overexpression of inhibitor of growth 4 enhances
radiosensitivity in non-small cell lung cancer cell line SPC-A1.
Technol Cancer Res Treat. 16:533–545. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ettinger DS, Akerley W, Borghaei H, Chang
AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R,
Grannis FW Jr, et al National comprehensive cancer network, :
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw.
11:645–653, quiz 653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistance of lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
You Q, Li H, Liu Y, Xu Y, Miao S, Yao G,
Xue Y, Geng J, Jin X and Meng H: MicroRNA-650 targets inhibitor of
growth 4 to promote colorectal cancer progression via mitogen
activated protein kinase signaling. Oncol Lett. 16:2326–2334.
2018.PubMed/NCBI
|
|
30
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with down-regulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu X, Chen H, Zhang Q, Xu J, Shi Q and
Wang M: MiR-650 inhibits proliferation, migration and invasion of
rheumatoid arthritis synovial fibroblasts by targeting AKT2. Biomed
Pharmacother. 88:535–541. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou C, Cui F, Li J, Wang D, Wei Y, Wu Y,
Wang J, Zhu H and Wang S: MiR-650 represses high-risk
non-metastatic colorectal cancer progression via inhibition of
AKT2/GSK3β/E-cadherin pathway. Oncotarget. 8:49534–49547.
2017.PubMed/NCBI
|
|
33
|
Li S, Fan T, Liu H, Chen J, Qin C and Ren
X: Tumor suppressor ING4 overexpression contributes to
proliferation and invasion inhibition in gastric carcinoma by
suppressing the NF-κB signaling pathway. Mol Biol Rep.
40:5723–5732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan S, Jin J, Shi J and Hou Y: Inhibitor
of growth-4 is a potential target for cancer therapy. Tumour Biol.
37:4275–4279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma Y, Cheng X, Wang F, Pan J, Liu J, Chen
H, Wang Y and Cai L: ING4 inhibits proliferation and induces
apoptosis in human melanoma A375 cells via the Fas/caspase-8
apoptosis pathway. Dermatology. 232:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qu H, Yin H, Yan S, Tao M, Xie Y and Chen
W: Inhibitor of growth 4 suppresses colorectal cancer growth and
invasion by inducing G1 arrest, inhibiting tumor angiogenesis and
reversing epithelial-mesenchymal transition. Oncol Rep.
35:2927–2935. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li M, Zhu Y, Zhang H, Li L, He P, Xia H,
Zhang Y and Mao C: Delivery of inhibitor of growth 4 (ING4) gene
significantly inhibits proliferation and invasion and promotes
apoptosis of human osteosarcoma cells. Sci Rep. 4:73802014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu X, Feng Y, Sun L, Qu L and Sun C: Roles
of microRNA-330 and its target gene ING4 in the development of
aggressive phenotype in hepatocellular carcinoma cells. Dig Dis
Sci. 62:715–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li S, Zeng A, Hu Q, Yan W, Liu Y and You
Y: miR-423-5p contributes to a malignant phenotype and temozolomide
chemoresistance in glioblastomas. Neuro Oncol. 19:55–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yan A, Yang C, Chen Z, Li C and Cai L:
MiR-761 promotes progression and metastasis of non-small cell lung
cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 37:55–66.
2015. View Article : Google Scholar : PubMed/NCBI
|
